Is the frequency of self-monitoring of blood glucose related to long-term metabolic control? Multicenter analysis including 24500 patients from 191 centers in Germany and Austria

Experimental and Clinical Endocrinology and Diabetes

Volumn 114, Issue 7, 2006, Pages 384-388

  Schutt M ^a   Kern, W ^b,l   Krause, U ^c   Busch, P ^d   Dapp, A ^e   Grziwotz, R ^f   Mayer, I ^g   Rosenbauer, J ^h   Wagner, C ⁱ   Zimmermann, A ^j   Kerner, W ^k   Holl, R W ^c  

^a Curschmann Klinik   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

^c UNIVERSITY OF ULM   (Germany)

^d SLK Kliniken Heilbronn GmbH   (Germany)

^e Diabeteszentrum Am Klinikum   (Germany)

^f Dialysezentrum/Schwerpunktpraxis   (Germany)

^g Kreiskrankenhaus Rastatt   (Germany)

^h HEINRICH HEINE UNIVERSITY   (Germany)

ⁱ Diabetes Schwerpunktpraxis ^*  (Germany)

^j Diabetes Schwerpunktpraxis   (Germany)

^k Heart and Diabetes Center Mecklenburg Vorpommern   (Germany)

^l UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN;

ARTICLE; BLOOD GLUCOSE MONITORING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; METABOLISM; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SELF MONITORING;

AUSTRIA; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DATABASES, FACTUAL; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; GERMANY; HOMEOSTASIS; HUMANS; PATIENT COMPLIANCE; SELF CARE;

EID: 33747597295     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-924152     Document Type: Article

References (16)

1. American Diabetes Association. Tests of glycemia in diabetes. Diabetes Care 2004; 27: S91-S93
2. Coster S, Gulliford MC, Seed PT, Powrie JK, Swaminathan R. Self-monitoring in type 2 diabetes mellitus: a meta-analysis. Diabet Med 2000; 17: 755-761
3. Davidson MB. Counterpoint: self-monitoring of blood glucose in type 2 diabetic patients not receiving insulin: a waste of money. Diabetes Care 2005; 28: 1531-1533
4. Franciosi M, Pellegrini F, de Berardis G et al. Self-monitoring of blood glucose in non-insulin-treated diabetic patients: a longitudinal evaluation of its impact on metabolic control. Diabet Med 2005; 22: 900-906
5. Gray A, Raikou M, McGuire A, Fenn P, Stevens R, Cull C, Stratton I, Adler A, Holman R, Turner R. Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41). United Kingdom Prospective Diabetes Study Group. BMJ 2000; 320: 1373-1378
6. Guerci B, Drouin P, Grange V, Bougneres P, Fontaine P, Kerlan V, Passa P, Thivolet C, Vialettes B, Charbonnel B, ASIA Group. Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) Study. Diabetes Metab 2003; 29: 587-594
7. Herman WH, Eastman RC The effects of treatment on the direct costs of diabetes. Diabetes Care 1998; 21: C19-C24
8. Ipp E, Aquino RL, Christenson P. Point: self-monitoring of blood glucose in type 2 diabetic patients not receiving insulin: the sanguine approach. Diabetes Care 2005; 28: 1528-1530
9. Karter AJ, Ackerson LM, Darbinian JA et al. Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes Registry. Am J Med 2001; 111: 1-9
10. Martin S, Schneider B, Heinemann L, Lodwig V, Kurth HJ, Kolb H, Scherbaum WA. Self-monitoring of blood glucose in type 2 diabetes and long-term outcome: an epidemiological cohort study. Diabetologia 2006; 49: 271-278
11. Murata GH, Shah JH, Hoffman RM, Wendel CS, Adam KD, Solvas PA, Bokhari SU, Duckworth WC, Diabetes Outcomes in Veterans Study (DOVES). Intensified blood glucose monitoring improves glycemic control in stable, insulin-treated veterans with type 2 diabetes: the Diabetes Outcomes in Veterans Study (DOVES). Diabetes Care 2003; 26: 1759-1763
12. O'Brien JA, Patrick AR, Caro J. Estimates of direct medical costs for microvascular and macrovascular complications resulting from type 2 diabetes mellitus in the United States in 2000. Clin Ther 2003; 25: 1017-1038
13. Schwedes U, Siebolds M, Mertes G, SMBG Study Group. Meal-related structured self-monitoring of blood glucose: effect on diabetes control in non-insulin-treated type 2 diabetic patients. Diabetes Care 2002; 25: 1928-1932
14. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986
15. UKPDS Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853
16. Welschen LM, Bloemendal E, Nijpels G, Dekker JM, Heine RJ, Stalman WA, Bouter LM. Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin. Cochrane Database Syst Rev 2005: CD005060